Valenti, Mario
Valenti, Mario
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)
2023-01-01 Gargiulo, L; Ibba, L; Malagoli, P; Amoruso, F; Argenziano, G; Balato, A; Bardazzi, F; Burlando, M; Carrera, C G; Damiani, G; Dapavo, P; Dini, V; Fabbrocini, G; Franchi, C; Gaiani, F M; Girolomoni, G; Guarneri, C; Lasagni, C; Loconsole, F; Marzano, A V; Maurelli, M; Megna, M; Orsini, D; Sampogna, F; Travaglini, M; Valenti, M; Costanzo, A; Narcisi, A
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study
2023-01-01 Ibba, Luciano; Gargiulo, Luigi; Alfano, Angela; Cascio Ingurgio, Ruggero; Narcisi, Alessandra; Costanzo, Antonio; Valenti, Mario
Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab
2023-01-01 Gargiulo, Luigi; Toso, Francesco; Ibba, Luciano; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra
Bullous vasculitis associated with Streptococcus pyogenes sepsis
2021-01-01 Pavia, Giulia; Gargiulo, Luigi; Facheris, Paola; Valenti, Mario; Brusa, Stefania; Manara, Sofia; Narcisi, Alessandra; Costanzo, Antonio; Borroni, Riccardo G.
Cutaneous toxicity of CAR T‐cell therapy: Case report of a bullous life‐threatening reaction
2023-01-01 Fiorillo, Giovanni; Toso, Francesco; Cortese, Andrea; Piscazzi, Francesco; Bressan, Alessandra; Bramanti, Stefania; Manara, Sofia; Narcisi, Alessandra; Costanzo, Antonio; Valenti, Mario
Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience
2023-01-01 Gargiulo, Luigi; Piscazzi, Francesco; Ibba, Luciano; Valenti, Mario; Facheris, Paola; Perugini, Chiara; Costanzo, Antonio; Narcisi, Alessandra
Effectiveness and safety of anti-IL-23 and anti-IL-17 biological therapies for psoriasis in elderly patients: Real-world experience from two Italian hospitals
2023-01-01 Fiorillo, G; Ibba, L; Gargiulo, L; Vignoli, C A; Alfano, A; Cortese, A; Toso, F; Orsini, D; Iacovelli, P; Frascione, P; Narcisi, A; Costanzo, A; Valenti, M
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers
2023-01-01 Orsini, Diego; Gargiulo, Luigi; Ibba, Luciano; Cascio Ingurgio, Ruggero; Valenti, Mario; Perugini, Chiara; Pacifico, Alessia; Maramao, Fabio S; Frascione, Pasquale; Costanzo, Antonio; Narcisi, Alessandra
Efficacy and safety of switching psoriatic patients to bimekizumab: new evidence from clinical trials
2023-01-01 Valenti, Mario; Costanzo, Antonio
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It?
2023-01-01 Gargiulo, Luigi; Ibba, Luciano; Cortese, Andrea; Alfano, Angela; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra
Long-term management of pediatric psoriasis with ixekizumab: a case report
2023-01-01 Orsini, Diego; Ibba, Luciano; Narcisi, Alessandra; Frascione, Pasquale; Pacifico, Alessia; Valenti, Mario; Costanzo, Antonio; Gargiulo, Luigi
Long-Term Sequential Digital Dermoscopy of Low-Risk Patients May Not Improve Early Diagnosis of Melanoma Compared to Periodical Handheld Dermoscopy
2023-01-01 Borroni, Riccardo G.; Panasiti, Vincenzo; Valenti, Mario; Gargiulo, Luigi; Perrone, Giuseppe; Dall’Alba, Roberta; Fava, Clarissa; Sacrini, Francesco; Mancini, Luca L.; Manara, Sofia A. A. M.; Morenghi, Emanuela; Costanzo, Antonio
New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series
2023-01-01 Gargiulo, Luigi; Ibba, Luciano; Vignoli, Carlo A.; Piscazzi, Francesco; Cortese, Andrea; Fiorillo, Giovanni; Toso, Francesco; Pavia, Giulia; Valenti, Mario; Avagliano, Jessica; Narcisi, Alessandra; Costanzo, Antonio
Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor-patient communication in avoiding drug discontinuation
2023-01-01 Valenti, Mario; Costanzo, Antonio
Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma
2023-01-01 Gargiulo, Luigi; Ibba, Luciano; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study
2023-01-01 Gargiulo, Luigi; Vignoli, Carlo Alberto; Ibba, Luciano; Cortese, Andrea; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study
2022-01-01 Gargiulo, Luigi; Ibba, Luciano; Pavia, Giulia; Vignoli, Carlo Alberto; Piscazzi, Francesco; Valenti, Mario; Sanna, Federica; Perugini, Chiara; Avagliano, Jessica; Costanzo, Antonio; Narcisi, Alessandra
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study
2023-01-01 Gargiulo, Luigi; Ibba, Luciano; Cortese, Andrea; Avagliano, Jessica; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis)
2023-01-01 Narcisi, Alessandra; Valenti, Mario; Gargiulo, Luigi; Ibba, Luciano; Amoruso, Fabrizio; Argenziano, Giuseppe; Bardazzi, Federico; Burlando, Martina; Carrera, Carlo Giovanni; Damiani, Giovanni; Dapavo, Paolo; Dini, Valentina; Franchi, Chiara; Girolomoni, Giampiero; Guarneri, Claudio; Loconsole, Francesco; Sampogna, Francesca; Travaglini, Massimo; Malagoli, Piergiorgio; Costanzo, Antonio
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study
2023-01-01 Ibba, Luciano; Gargiulo, Luigi; Vignoli, Carlo Alberto; Fiorillo, Giovanni; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS) | 1-gen-2023 | Gargiulo, L; Ibba, L; Malagoli, P; Amoruso, F; Argenziano, G; Balato, A; Bardazzi, F; Burlando, M; Carrera, C G; Damiani, G; Dapavo, P; Dini, V; Fabbrocini, G; Franchi, C; Gaiani, F M; Girolomoni, G; Guarneri, C; Lasagni, C; Loconsole, F; Marzano, A V; Maurelli, M; Megna, M; Orsini, D; Sampogna, F; Travaglini, M; Valenti, M; Costanzo, A; Narcisi, A | |
| Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study | 1-gen-2023 | Ibba, Luciano; Gargiulo, Luigi; Alfano, Angela; Cascio Ingurgio, Ruggero; Narcisi, Alessandra; Costanzo, Antonio; Valenti, Mario | |
| Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab | 1-gen-2023 | Gargiulo, Luigi; Toso, Francesco; Ibba, Luciano; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra | |
| Bullous vasculitis associated with Streptococcus pyogenes sepsis | 1-gen-2021 | Pavia, Giulia; Gargiulo, Luigi; Facheris, Paola; Valenti, Mario; Brusa, Stefania; Manara, Sofia; Narcisi, Alessandra; Costanzo, Antonio; Borroni, Riccardo G. | |
| Cutaneous toxicity of CAR T‐cell therapy: Case report of a bullous life‐threatening reaction | 1-gen-2023 | Fiorillo, Giovanni; Toso, Francesco; Cortese, Andrea; Piscazzi, Francesco; Bressan, Alessandra; Bramanti, Stefania; Manara, Sofia; Narcisi, Alessandra; Costanzo, Antonio; Valenti, Mario | |
| Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience | 1-gen-2023 | Gargiulo, Luigi; Piscazzi, Francesco; Ibba, Luciano; Valenti, Mario; Facheris, Paola; Perugini, Chiara; Costanzo, Antonio; Narcisi, Alessandra | |
| Effectiveness and safety of anti-IL-23 and anti-IL-17 biological therapies for psoriasis in elderly patients: Real-world experience from two Italian hospitals | 1-gen-2023 | Fiorillo, G; Ibba, L; Gargiulo, L; Vignoli, C A; Alfano, A; Cortese, A; Toso, F; Orsini, D; Iacovelli, P; Frascione, P; Narcisi, A; Costanzo, A; Valenti, M | |
| Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers | 1-gen-2023 | Orsini, Diego; Gargiulo, Luigi; Ibba, Luciano; Cascio Ingurgio, Ruggero; Valenti, Mario; Perugini, Chiara; Pacifico, Alessia; Maramao, Fabio S; Frascione, Pasquale; Costanzo, Antonio; Narcisi, Alessandra | |
| Efficacy and safety of switching psoriatic patients to bimekizumab: new evidence from clinical trials | 1-gen-2023 | Valenti, Mario; Costanzo, Antonio | |
| Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It? | 1-gen-2023 | Gargiulo, Luigi; Ibba, Luciano; Cortese, Andrea; Alfano, Angela; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra | |
| Long-term management of pediatric psoriasis with ixekizumab: a case report | 1-gen-2023 | Orsini, Diego; Ibba, Luciano; Narcisi, Alessandra; Frascione, Pasquale; Pacifico, Alessia; Valenti, Mario; Costanzo, Antonio; Gargiulo, Luigi | |
| Long-Term Sequential Digital Dermoscopy of Low-Risk Patients May Not Improve Early Diagnosis of Melanoma Compared to Periodical Handheld Dermoscopy | 1-gen-2023 | Borroni, Riccardo G.; Panasiti, Vincenzo; Valenti, Mario; Gargiulo, Luigi; Perrone, Giuseppe; Dall’Alba, Roberta; Fava, Clarissa; Sacrini, Francesco; Mancini, Luca L.; Manara, Sofia A. A. M.; Morenghi, Emanuela; Costanzo, Antonio | |
| New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series | 1-gen-2023 | Gargiulo, Luigi; Ibba, Luciano; Vignoli, Carlo A.; Piscazzi, Francesco; Cortese, Andrea; Fiorillo, Giovanni; Toso, Francesco; Pavia, Giulia; Valenti, Mario; Avagliano, Jessica; Narcisi, Alessandra; Costanzo, Antonio | |
| Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor-patient communication in avoiding drug discontinuation | 1-gen-2023 | Valenti, Mario; Costanzo, Antonio | |
| Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma | 1-gen-2023 | Gargiulo, Luigi; Ibba, Luciano; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra | |
| Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study | 1-gen-2023 | Gargiulo, Luigi; Vignoli, Carlo Alberto; Ibba, Luciano; Cortese, Andrea; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra | |
| Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study | 1-gen-2022 | Gargiulo, Luigi; Ibba, Luciano; Pavia, Giulia; Vignoli, Carlo Alberto; Piscazzi, Francesco; Valenti, Mario; Sanna, Federica; Perugini, Chiara; Avagliano, Jessica; Costanzo, Antonio; Narcisi, Alessandra | |
| Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study | 1-gen-2023 | Gargiulo, Luigi; Ibba, Luciano; Cortese, Andrea; Avagliano, Jessica; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra | |
| Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis) | 1-gen-2023 | Narcisi, Alessandra; Valenti, Mario; Gargiulo, Luigi; Ibba, Luciano; Amoruso, Fabrizio; Argenziano, Giuseppe; Bardazzi, Federico; Burlando, Martina; Carrera, Carlo Giovanni; Damiani, Giovanni; Dapavo, Paolo; Dini, Valentina; Franchi, Chiara; Girolomoni, Giampiero; Guarneri, Claudio; Loconsole, Francesco; Sampogna, Francesca; Travaglini, Massimo; Malagoli, Piergiorgio; Costanzo, Antonio | |
| Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study | 1-gen-2023 | Ibba, Luciano; Gargiulo, Luigi; Vignoli, Carlo Alberto; Fiorillo, Giovanni; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra |